Please login to the form below

Not currently logged in
Email:
Password:

Hans Lennernas joins board of CMO Recipharm

He is currently professor of biopharmaceuticals at Uppsala University

Sweden-based contract manufacturing organisation (CMO) Recipharm has appointed Professor Hans Lennernäs to its board of directors.

Prof Lennernäs is currently a professor of biopharmaceuticals at Uppsala University in Sweden, where he manages an Innovative Medicines Initiative (IMI) project called OrBiTo, which aims to improve the delivery of oral drugs.

Other industry experience includes serving as principle investigator in a collaborative project between US drug regulator the FDA, the University of Michigan and the Medical Product Agency in Sweden to develop a new guideline for the biopharmaceuticals classification systems.

Prof Lennernäs has also helped to launch several life sciences companies, including DuoCort Pharma and LIDDS.

“We are very pleased to welcome a board member of Hans Lennernäs calibre,” said Maria Lundberg, manager of Recipharm, which supplies pharma companies with products such as solid dose medicines, granulates and powders, sterile liquids and lyophilisates, hormones, oral liquids, sprays and dry powder inhalers.

“His track record of successfully inventing and developing several novel drug delivery systems that are currently in pre-clinical phase and in preparation for phase I, II and III clinical trials, makes him an excellent addition to the board.”

6th February 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics